Chancellor Reeves Intends Focused Action on Living Costs in Forthcoming Budget
Chancellor Reeves has revealed she is preparing "targeted steps to deal with cost of living challenges" in the forthcoming Budget.
In comments to media outlets, she noted that curbing price rises is a joint duty of both the administration and the Bank of England.
The UK's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this year and the following year.
Possible Energy Bill Measures
It is understood the government could intervene to lower utility costs, such as by slashing the present 5% rate of VAT applied on energy supplies.
An additional approach is to reduce some of the regulatory levies presently included in household expenses.
Budgetary Constraints and Expert Predictions
The administration will receive the latest report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for these actions.
The view from most experts is that the Chancellor will have to announce tax rises or expenditure reductions in order to adhere to her declared debt limits.
Previously on the same day, estimates showed there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the more modest range of forecasts.
"There's a joint responsibility between the central bank and the administration to further reduce some of the causes of inflation," the Chancellor stated to reporters in Washington, at the annual meetings of the IMF and World Bank.
Revenue Pledges and International Concerns
While much of the attention has been on probable tax rises, the chancellor said the most recent data from the OBR had not altered her vow to campaign commitments not to increase tax levels on earnings tax, sales tax or National Insurance.
She blamed an "unpredictable world" with growing international and trade concerns for the Budget tax moves, likely to be directed on those "with the broadest shoulders."
International Trade Disputes
Commenting on apprehensions about the UK's economic relations with the Asian nation she said: "Our national security invariably take priority."
Last week's statement by Chinese authorities to increase trade restrictions on critical minerals and other materials that are essential for high-technology manufacturing led US President the US President to threaten an further 100% tariff on goods from China, raising the possibility of an all-out trade war between the two economic giants.
The American finance chief called the Chinese action "commercial pressure" and "a global supply chain control attempt."
Questioned on considering the American proposal to join its conflict with China, Reeves said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and restrict access."
She said the decision was "bad for the global economy and creates further obstacles."
"It is my opinion there are sectors where we must challenge China, but there are also significant prospects to export to Chinese markets, including financial services and other sectors of the economic system. We've got to get that balance appropriate."
The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own critical minerals approach, so that we are less reliant."
NHS Medicine Costs and Investment
The Chancellor also admitted that the price the National Health Service spends on medicines could go up as a result of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and funding.
Some of the world's largest drug companies have said lately that they are either delaying or scrapping operations in the United Kingdom, with several blaming the insufficient payments they are receiving.
Last month, the Science Minister said the price the health service pays for drugs would have to increase to halt firms and pharmaceutical investment leaving the United Kingdom.
Reeves informed media: "It has been observed because of the payment system, that clinical trials, new drugs have not been provided in the United Kingdom in the way that they are in other European countries."
"The objective is to guarantee that individuals receiving care from the NHS are can obtain the best life-saving medicines in the globe. And so we are looking at all of that, and... looking to obtain additional funding into the UK."